OFLOVAS-M Suspension

OFLOVAS-M Suspension

OFLOVAS-M Suspension is a pharmaceutical formulation combining Ofloxacin and Metronidazole in a liquid dosage form. Each specified dose contains Ofloxacin 50 mg and Metronidazole 100 mg, as listed in the product composition. This combination brings together two established pharmaceutical ingredients with distinct antimicrobial properties in a single oral suspension formulation.

Ofloxacin belongs to the fluoroquinolone class of antibacterial agents, while Metronidazole is an antimicrobial agent with activity against susceptible anaerobic microorganisms and certain protozoa. The combination is classified within the antibiotic and antiprotozoal product segment of the pharmaceutical portfolio.

The suspension dosage form provides a liquid presentation for pharmaceutical supply channels and healthcare settings where liquid formulations are required. OFLOVAS-M Suspension is supplied in a 60 ml pack, with the product name, active ingredients and dosage form clearly identified for inventory and procurement records.

Everything You, Need to Know

OFLOVAS-M Suspension is listed in a 60 ml pack.

OFLOVAS-M is available as an oral suspension.

OFLOVAS-M Suspension contains Ofloxacin 50 mg and Metronidazole 100 mg, as specified in its product composition.